The option of compassionate use in metastatic melanoma - Way out of a therapeutic dilemma?

2Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Metastasized melanoma has an unfavorable prognosis. Therefore there is strong need for new innovative therapies. In cases in which standard therapies have failed and inclusion in clinical studies is not possible due to diverse causes, the option of compassionate use now opens new therapeutic windows. Compassionate use describes the use of not (yet) approved drugs for humanitarian reasons. It was legally established in Germany through drug laws issued in 2006. We describe legal aspects of compassionate use are discussed, taking two of our cases as examples. Finally, examples for necessary documents to apply for compassionate use are provided. © Blackwell Verlag GmbH, Berlin.

Cite

CITATION STYLE

APA

Tsianakas, A., Schiller, M., Luger, T. A., & Sunderkötter, C. (2009). The option of compassionate use in metastatic melanoma - Way out of a therapeutic dilemma? JDDG - Journal of the German Society of Dermatology. Blackwell Publishing Ltd. https://doi.org/10.1111/j.1610-0387.2009.07028.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free